Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization | Zendy

Christian M Gill | Zendy; Elif Aktaş | Zendy; Wadha Alfouzan | Zendy; Lori Bourassa | Zendy; Adrian Brink | Zendy; CareyAnn D. Burnham | Zendy; Rafael Cantón | Zendy; Yehuda Carmeli | Zendy; Marco Falcone | Zendy; Carlos Roberto Veiga Kiffer | Zendy; Anna Marchese | Zendy; Octavio Martínez | Zendy; Spyros Pournaras | Zendy; Harald Seifert | Zendy; Abrar K. Thabit | Zendy; María Virginia Villegas | Zendy; Lars F. Westblade | Zendy; David P. Nicolau | Zendy

Open Access

Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization

Author(s) -

Christian M Gill,

Elif Aktaş,

Wadha Alfouzan,

Lori Bourassa,

Adrian Brink,

CareyAnn D. Burnham,

Rafael Cantón,

Yehuda Carmeli,

Marco Falcone,

Carlos Roberto Veiga Kiffer,

Anna Marchese,

Octavio Martínez,

Spyros Pournaras,

Harald Seifert,

Abrar K. Thabit,

María Virginia Villegas,

Lars F. Westblade,

David P. Nicolau

Publication year - 2021

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01204-21

Subject(s) - cefepime , cephalosporin , ceftazidime , pseudomonas aeruginosa , pharmacodynamics , microbiology and biotechnology , carbapenem , population , medicine , meropenem , potency , pharmacokinetics , pharmacology , biology , antibiotics , antibiotic resistance , in vitro , bacteria , genetics , environmental health , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research